U.S., May 1 -- ClinicalTrials.gov registry received information related to the study (NCT06393998) titled 'CO2 Supplement for Treatment of Acute Mountain Sickness' on April 20.
Brief Summary: It was reported that up to 76% people who rapidly ascend to the altitude higher than 4500 m without sufficient acclimatization will have AMS which often develops 6-8 hours after reaching at high altitude. AMS could be improved if there is no continuous ascent although central sleep apnea may persist much longer. It has also been well documented that exercise capacity was impaired at high altitude. Oxygen inhalation is the most effective treatment method, but it is impractical for outdoor activities because of the large volume required. There are some ...